ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,068,181 | -89.7% | 568,182 | -80.0% | 0.12% | -83.7% |
| Q2 2023 | $10,369,314 | +533.7% | 2,840,908 | -0.0% | 0.72% | +528.1% |
| Q1 2023 | $1,636,364 | +159857.4% | 2,840,909 | 0.0% | 0.11% | -3.4% |
| Q4 2022 | $1,023 | -99.9% | 2,840,909 | 0.0% | 0.12% | -37.2% |
| Q3 2022 | $1,701,000 | +21.0% | 2,840,909 | 0.0% | 0.19% | +33.3% |
| Q2 2022 | $1,406,000 | -45.0% | 2,840,909 | 0.0% | 0.14% | -19.9% |
| Q1 2022 | $2,556,000 | -19.7% | 2,840,909 | 0.0% | 0.18% | -8.3% |
| Q4 2021 | $3,182,000 | -37.1% | 2,840,909 | 0.0% | 0.19% | -15.4% |
| Q3 2021 | $5,057,000 | -46.1% | 2,840,909 | 0.0% | 0.23% | -44.1% |
| Q2 2021 | $9,375,000 | -1.5% | 2,840,909 | 0.0% | 0.41% | +21.6% |
| Q1 2021 | $9,517,000 | – | 2,840,909 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |